Novavax Offers U.S. a Fourth Strong Covid-19 Vaccine

By Carl Zimmer from NYT Health https://ift.tt/2U8zjPD
via IFTTT Novavax Offers U.S. a Fourth Strong Covid-19 Vaccine The company’s large U.S. trial found an efficacy rate of about 90 percent. But at this point, the nation is awash in other shots. Health New York Times June 13, 2021 at 07:00PM